100 mg/day) showed a trend towards improved efficacy in subgroups of patients (APACHE II score >20, neutropenia) and might be used in selected patients [ 19 , 36 , 128 ].
← all excerpts
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
1
—
—